Back

Repeated histological diagnoses and kidney graft failure: an observational cohort study

Vranken, A.; Coemans, M.; Bemelman, F. J.; Chauveau, B.; Debyser, T.; Florquin, S.; Koshy, P.; Kuypers, D.; Masset, C.; Pagliazzi, A.; Vanhoutte, T.; Wellekens, K.; Vaulet, T.; Kers, J.; de Vries, A. P. J.; Meziyerh, S.; Verbeke, G.; Naesens, M.

2026-02-18 transplantation
10.64898/2026.02.17.26346474 medRxiv
Show abstract

BackgroundThe effects of Banff histological diagnoses on kidney transplant outcome have been well characterized. However, repeated observation of such histological injury across multiple biopsies in kidney transplant recipients remains insufficiently explored. MethodsIn an observational cohort (N=1819 transplantations with 5736 post-transplant biopsies, recurrent event survival models quantified transitions between diagnoses of T-cell mediated rejection (TCMR), antibody-mediated rejection (AMR), DSA-negative C4d-negative microvascular inflammation (MVIDSA-/C4d-), BK polyomavirus nephropathy (BKPyVAN), borderline TCMR (bTCMR), and probable AMR (pAMR), revealing patterns in the disease trajectories. In two observational cohorts (N=1818 transplantations with 5732 biopsies, N=853 transplantations with 975 biopsies), time-dependent cumulative covariates were constructed for TCMR, AMR, MVIDSA-/C4d- and BKPyVAN, enabling estimation of associations of repeated diagnoses with graft failure using multivariable cause-specific Cox models. ResultsThe incidence rate of a diagnosis was most strongly associated with earlier diagnosis of the same type, but associations between different types of diagnoses also occurred. The hazard of kidney graft failure was significantly increased by repeated observation of TCMR in multiple biopsies (HR 7.97, 95% CI 4.94 - 12.86), as well as by repeated AMR (HR 6.19, 95% CI 3.15 - 12.17), repeated MVIDSA-/C4d- (HR 4.53, 95% CI 2.15-9.54) and repeated BKPyVAN (HR 10.90, 95% CI 5.83 - 20.35). The hazard of graft failure was increased more after repeated diagnoses in transplants than after first diagnoses. The effects of repeated TCMR and repeated AMR remained significant even when observed in protocol biopsies in the absence of graft dysfunction. Repeated observation of BKPyVAN was the most detrimental of all diagnoses when observed in indication biopsies, but it was the least harmful when observed in protocol biopsies. ConclusionIncidence of Banff histological diagnoses appears to be affected by earlier diagnoses, especially those of the same type. These repeated observations of a specific diagnosis have an additional effect on the hazard of graft failure, underscoring a critical unmet need for adequate treatment strategies for these recurrent or persistent injury processes. Lay summaryIn two observational cohorts of 1819 and 750 kidney transplant recipients, kidney transplant biopsies were taken at multiple time points after transplantation. Based on the Banff classification for transplant pathology, various post-transplant diseases were diagnosed, often at more than one time point during follow-up. We assessed patterns in the occurrence of diagnoses over time, and related these diagnoses to survival of the kidney grafts using survival models with time-dependent cumulative diagnoses. We found that repeated observation of the same diagnosis was much more common than consecutive observations of different diagnoses. Repeated diagnoses of tissue injury also decreased kidney graft survival more compared to single diagnoses. This indicates that treatment options for patients with repeated or persistent diagnoses are currently inadequate and novel strategies are needed.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Transplantation
13 papers in training set
Top 0.1%
28.9%
2
American Journal of Transplantation
15 papers in training set
Top 0.1%
19.4%
3
Annals of Internal Medicine
27 papers in training set
Top 0.1%
7.5%
50% of probability mass above
4
Kidney International
25 papers in training set
Top 0.1%
7.5%
5
Journal of the American Society of Nephrology
52 papers in training set
Top 0.2%
6.7%
6
PLOS ONE
4510 papers in training set
Top 37%
3.7%
7
JAMA Network Open
127 papers in training set
Top 0.8%
3.7%
8
Frontiers in Immunology
586 papers in training set
Top 3%
2.5%
9
Kidney360
22 papers in training set
Top 0.3%
2.2%
10
The Journal of Heart and Lung Transplantation
10 papers in training set
Top 0.1%
1.8%
11
Journal of Clinical Investigation
164 papers in training set
Top 3%
1.7%
12
JCI Insight
241 papers in training set
Top 4%
1.4%
13
The Journal of Infectious Diseases
182 papers in training set
Top 3%
1.4%
14
Journal of Clinical Medicine
91 papers in training set
Top 4%
1.3%
15
Frontiers in Pharmacology
100 papers in training set
Top 3%
0.9%
16
Scientific Reports
3102 papers in training set
Top 70%
0.9%
17
Nature Communications
4913 papers in training set
Top 59%
0.9%
18
Frontiers in Public Health
140 papers in training set
Top 7%
0.8%
19
BMC Medicine
163 papers in training set
Top 6%
0.8%
20
npj Regenerative Medicine
21 papers in training set
Top 0.3%
0.8%
21
BMJ Open
554 papers in training set
Top 13%
0.7%